This further demonstrates the value of the Mtm1−/y mouse as a model for XLMTM15,38,39,40 and supports future translation of tamoxifen efficacy findings from Mtm1−/y mice to XLMTM patients.
This information is important in designing and implementing CER to accelerate translation of clinical efficacy into effectiveness.
This shift is exciting, as we and many others hope it not only will support translation of drug efficacy from animal models to clinical trials but also will potentially improve predictability of stage II for stage III clinical trials.
In particular, we discuss the poor translation of drug efficacy from preclinical animal models, inappropriate end point analysis, limited standards in phase I clinical trials, insufficient use of biomarker analysis and also patient stratification, all of which contributed to the failure to achieve approval of enzastaurin as an anticancer therapeutic.
More systematic research in this area appears to be warranted, particularly with respect to how the external validity of a trial then affects the 'translation' of efficacy to effectiveness.
Each chapter (written by recognised melanoma experts) stands independently as a comprehensive extensively referenced review of both the scientific data relating to the particular sub-theme, its consequent clinical translation and evidence of efficacy, repeatedly illustrating the key concepts of rational new drug design.
12– 18 A substantial push to further improve 3D models and integrate them to improve translation of preclinical pharmacokinetics, efficacy, and toxicology results from lab to clinic arose recently with establishment in 2012 of the Microphysiological Systems program by the United States Defense Advanced Research Projects Agency, National Institutes of Health, and Food and Drug Administration.
Such high level of preexisting immunity may significantly hamper clinical translation and efficacy of Ad5 vectors, and consequently a great deal of effort has therefore been placed on developing means to evade preexisting Ad5 immunity, either genetically or chemically, using hydrophilic polymers such as pHPMA or PEG.
We will use the English translation of the Generalized Self-Efficacy Scale (GSES)[ 61] to measure generalised self-efficacy in relation to the five tracer activities.
Since in a yeast super-killer ski3 mutant (defective in exosome complex components) translation efficacy of the poly(A)− transcript of L-A is more effective and dsRNA copy number is significantly increased [43], [44], a Δski3 variant of strain BY4741 [MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Δski3] (Euroscarf) was used to prepare natural L-A virions.
